glp-1 review article Discovery of GLP-1–Based Drugs for the Treatment of Obesity Dual GIP/GLP-1 receptor agonists: New

Obesity For weight loss, healthcare professionals may prescribe GLP-1 agonists for people with an initial BMI of 30 or higher or people who have a BMI of 27 or higher and at least one weight-related health condition, such as: type 2 diabetes prediabetes high blood pressure high cholesterol heart disease nonalcoholic fatty liver disease obstructive sleep apnea polycystic ovary syndrome Typically, healthcare professionals only prescribe these medications after someone has tried other weight loss methods, such as diet and exercise, without success

Fiber-Packed for Wellness Formulated as a fiber supplement for women and men, this convenient beverage delivers 5 grams of fiber per serving, making it an easy way to add more fiber to your diet and help maintain gut health as part of your daily routine

Furthermore, Ozempic comes with several potential side effects, including nausea, fatigue, and more serious health risks like thyroid issues

They work through appetite and metabolic pathways, not by directly altering estrogen, progesterone, or testosterone levels

Meanwhile, Alfa Lipoic Acid and L-Taurine energize and rejuvenate, making you feel vibrant and balanced

Critics argue that doctors are too quick to prescribe them for weight loss and that people may be drawn to their fast results over making long-term lifestyle changes